A Dual Mechanism-Based Physiologically Based Pharmacokinetic Model for Predicting Mitoxantrone and Liposomal Mitoxantrone Disposition: Preclinical Validation in Rats and Human Extrapolation with Clinical Evaluation
International Journal of Nanomedicine · 2026
DOI: 10.2147/ijn.s638932 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Yuxiang Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, People's Republic of China. Hauptthemen laut MEDLINE: Mitoxantrone, Liposomes, Models, Biological. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, People's Republic of China.
ORCID-Profile: Yuxiang Xu, Xiaonan Gao, Jinglin Gao, Zhangying Feng
Zitieren
APA
Xu, Y., Li, S., Yang, Z., Qiu, Y., Dong, J., Gao, X., Gao, J., Feng, Z., & Wang, M. (2026). A Dual Mechanism-Based Physiologically Based Pharmacokinetic Model for Predicting Mitoxantrone and Liposomal Mitoxantrone Disposition: Preclinical Validation in Rats and Human Extrapolation with Clinical Evaluation. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s638932
Vancouver
Xu Y, Li S, Yang Z, Qiu Y, Dong J, Gao X, et al. A Dual Mechanism-Based Physiologically Based Pharmacokinetic Model for Predicting Mitoxantrone and Liposomal Mitoxantrone Disposition: Preclinical Validation in Rats and Human Extrapolation with Clinical Evaluation. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s638932
BibTeX
@article{Xu2026,
author = {Xu, Yuxiang and Li, Shuo and Yang, Zhixuan and Qiu, Yushuo and Dong, Jiameng and Gao, Xiaonan and Gao, Jinglin and Feng, Zhangying and Wang, Mingxia},
title = {A Dual Mechanism-Based Physiologically Based Pharmacokinetic Model for Predicting Mitoxantrone and Liposomal Mitoxantrone Disposition: Preclinical Validation in Rats and Human Extrapolation with Clinical Evaluation},
journal = {International Journal of Nanomedicine},
year = {2026},
doi = {10.2147/ijn.s638932}
}
EUVIMED